Combining thrombolytic agents to treat acute myocardial infarction

Editorial

P Ott et al. Am Heart J. 1991 May.

. 1991 May;121(5):1583-4.

doi: 10.1016/0002-8703(91)90179-l.

No abstract available

Similar articles

The effects of combined thrombolytic and platelet inhibitor therapy on myocardial and microvascular perfusion.
de Lemos J. de Lemos J. Md Med. 2001 Spring;Suppl:88-9. Md Med. 2001. PMID: 11434069 Review. No abstract available.
Intravenous thrombolysis in acute myocardial infarction.
Ohman EM, Harrington RA, Cannon CP, Agnelli G, Cairns JA, Kennedy JW. Ohman EM, et al. Chest. 2001 Jan;119(1 Suppl):253S-277S. doi: 10.1378/chest.119.1_suppl.253s. Chest. 2001. PMID: 11157653 Review. No abstract available.
[Intravenous thrombolytic therapy in myocardial infarction (review)].
Staroverov II. Staroverov II. Ter Arkh. 2003;75(10):80-3. Ter Arkh. 2003. PMID: 14669614 Review. Russian. No abstract available.
[Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
Franzosi MG. Franzosi MG. Ital Heart J Suppl. 2001 Sep;2(9):1034-6. Ital Heart J Suppl. 2001. PMID: 11675828 Italian. No abstract available.
[Management of acute myocardial infarction: What remains of intravenous thrombolysis?].
Bonnet JL, Bonnet G. Bonnet JL, et al. Presse Med. 2011 Jun;40(6):611-4. doi: 10.1016/j.lpm.2011.02.040. Epub 2011 May 12. Presse Med. 2011. PMID: 21570245 Review. French.

Advances in thrombolytic therapy.
Verstraete M. Verstraete M. Cardiovasc Drugs Ther. 1992 Apr;6(2):111-24. doi: 10.1007/BF00054557. Cardiovasc Drugs Ther. 1992. PMID: 1390321 Review.